INTENDED FOR UK HEALTHCARE PROFESSIONALS
Fostair® logo (beclometasone/formoterol) Extrafine formulation 100/6 & 200/6
Background
Fostair® logo (beclometasone/formoterol) Extrafine formulation 100/6 & 200/6 - Fostair® NEXThaler® and pMDI devices

Fostair® in COPD

The following Fostair presentations can be used for the symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal), each delivering 120 inhalations per device.1,2
  • Fostair NEXThaler 100/6
  • Fostair pMDI 100/6
Fostair® NEXThaler and pMDI devices
The following Fostair presentations can be used for the symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal), each delivering 120 inhalations per device.1,2
  • Fostair NEXThaler 100/6
  • Fostair pMDI 100/6
Comparable efficacy
  • Fostair NEXThaler has demonstrated comparable efficacy to Fostair pMDI across a variety of lung function measures1
  • Both Fostair pMDI and Fostair NEXThaler are characterised by an extrafine particle size distribution

Fostair‘s extrafine particle size distribution results in a more potent effect than formulations of beclometasone with a non-extrafine particle size distribution2

100mcg of extrafine beclometasone in Fostair is equivalent to 250mcg of non-extrafine beclometasone2

For additional information to share with your patients who have been prescribed Fostair NEXThaler or Fostair pMDI please visit our Fostair NEXThaler patient and carer site or Fostair pMDI patient and carer site.
References:
1. Fostair NEXThaler 100/6 Summary of Product Characteristics. Chiesi Limited.
2. Fostair pMDI 100/6 Summary of Product Characteristics. Chiesi Limited.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.

Disclaimer

The purpose of this section of the website is to provide UK healthcare professionals with accurate and relevant information on Chiesi Limited respiratory products.

The contents of this area of the website are intended solely for the use of UK healthcare professionals. If you are NOT a UK healthcare professional, please exit this section of the website.

YES I AM

a UK healthcare professional

NO I'M NOT

a UK healthcare professional

UK-RES-1900858 Jun 2019